(Q74361369)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Esophageal involvement and pulmonary manifestations in systemic sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

Marie I

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Dominique S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Levesque H

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Ducrotté P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Denis P

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Hellot MF

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Courtois H

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

346-354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11501722%20AND%20SRC:MED&resulttype=core&format=json

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

[Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

[Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

The lungs in systemic sclerosis (scleroderma): a review and new information

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Pulmonary involvement in systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Scleroderma. Clinical problems. The lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Interstitial lung disease of systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Predictors of survival in systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

D-penicillamine therapy and interstitial lung disease in scleroderma. A long-term followup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Progressive systemic sclerosis: mode of presentation, rapidly progressive disease course, and mortality based on an analysis of 91 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Diffusing capacity of the lung and nifedipine in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Isolated diffusing capacity reduction in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Severe restrictive lung disease in systemic sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Epidemiology of scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Esophageal Motility and Pulmonary Function in Progressive Systemic Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Gastrointestinal motility disorders in scleroderma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Esophageal manometry and 24-hour pH monitoring in the diagnosis of pulmonary aspiration secondary to gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Gastrointestinal manifestations of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Gastric involvement in systemic sclerosis: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Pulmonary aspiration as a consequence of gastroesophageal reflux: a diagnostic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Simultaneous tracheal and esophageal pH monitoring: investigating reflux-associated asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Medical and surgical treatment of nonallergic asthma associated with gastroesophageal reflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Gastroesophageal reflux and diseases of the respiratory tract: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Diffuse pulmonary fibrosis and hiatus hernia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Typical and atypical presentations of gastroesophageal reflux disease. The role of esophageal testing in diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

Pulmonary function and gastroesophageal reflux in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200108%2945%3A4%3C346%3A%3AAID-ART347%3E3.0.CO%3B2-L

10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L

21 January 2018

Identifiers

DOI

0 references

1 reference